| Brand Name | Remicade |
| Generic Name | Infliximab |
| Drug Class | JAK Inhibitor |
| Availability | Prescription |
| Manufacturer | Janssen Biotech (Johnson & Johnson) |
| Indications | Crohn's Disease, Ulcerative Colitis |
| Type | IV Infusion |
| Doses | Initial dose: 5 mg/kg at weeks 0, 2, and 6, then every 8 weeks |
| Route | IV infusion |
| Side Effects | Infusion reactions, infections, headache, abdominal pain |
| Interactions | May interact with immunosuppressants, live vaccines |
| Overdose | Infusion reaction, increased infection risk. |
| Missed Dose | Contact provider to reschedule (IV infusion). |
| Contraindications | Systemic fungal infections, live vaccines. |
| Alternatives | Adalimumab, Golimumab, Vedolizumab |
| Co-Pay Assistance Program | Available |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Infliximab is used to treat autoimmune diseases such as rheumatoid arthritis, Crohn�s disease, ulcerative colitis, and ankylosing spondylitis by reducing inflammation in the body.
Infliximab works by blocking the action of tumor necrosis factor (TNF), a protein involved in inflammation, thereby reducing inflammation and immune system activity in autoimmune diseases.
Common side effects include headache, nausea, fatigue, and upper respiratory infections. Serious side effects may include infections, heart failure, and liver damage.
Infliximab is administered as an intravenous (IV) infusion in a healthcare setting, typically every few weeks depending on the condition being treated.
Infliximab should only be used during pregnancy if the benefits outweigh the risks. Consult your healthcare provider if you are pregnant or planning to become pregnant.
If you miss a dose, contact your healthcare provider to reschedule your infusion. Do not attempt to make up for a missed dose on your own.
Yes, Infliximab can suppress the immune system and increase the risk of infections. It is important to monitor for signs of infection and seek prompt medical attention if symptoms arise.
Yes, Infliximab is used for various autoimmune conditions, including psoriatic arthritis, Crohn�s disease, ulcerative colitis, and ankylosing spondylitis, depending on your doctor�s recommendations.
Infliximab may take several weeks to show noticeable effects, especially for chronic inflammatory conditions like Crohn�s disease or rheumatoid arthritis.
Yes, Infliximab can interact with other medications, especially immunosuppressive drugs. Always inform your healthcare provider about all medications you are taking.
Related Conditions |
Related Blogs |
|---|---|
